The Pediatric Cardiomyopathy Registry (PCMR) was established to describe th
e epidemiologic features and clinical course of selected cardiomyopathies i
n patients aged 18 years or younger and to promote the development of etiol
ogy-specific treatments. Sixty-one private and institutional pediatric card
iomyopathy practices in the United States and Canada were recruited to part
icipate in the PCMR. The registry consists of a prospective, population-bas
ed cohort of patients in 2 regions (New England and the Central Southwester
n United States) and a retrospective cohort of patients diagnosed between 1
991 and 1996. Annual follow-up data are collected on all patients. As of Ju
ne 1999, the PCMR consisted of 337 prospectively identified and 990 retrosp
ectively identified patients. The PCMR has demonstrated the feasibility of
establishing a large database of sociodemographic and clinical information
on children with pediatric cardiomyopathy. Through this cooperative effort,
the PCMR will obtain precise estimates of the incidence of pediatric cardi
omyopathy and a better understanding of the natural history of this disease
.